164 related articles for article (PubMed ID: 33246135)
1. Enterohepatic Transcription Factor CREB3L3 Protects Atherosclerosis via SREBP Competitive Inhibition.
Nakagawa Y; Wang Y; Han SI; Okuda K; Oishi A; Yagishita Y; Kumagai K; Ohno H; Osaki Y; Mizunoe Y; Araki M; Murayama Y; Iwasaki H; Konishi M; Itoh N; Matsuzaka T; Sone H; Yamada N; Shimano H
Cell Mol Gastroenterol Hepatol; 2021; 11(4):949-971. PubMed ID: 33246135
[TBL] [Abstract][Full Text] [Related]
2. Loss of Transcription Factor CREBH Accelerates Diet-Induced Atherosclerosis in Ldlr-/- Mice.
Park JG; Xu X; Cho S; Lee AH
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1772-81. PubMed ID: 27417587
[TBL] [Abstract][Full Text] [Related]
3. Intestinal CREBH overexpression prevents high-cholesterol diet-induced hypercholesterolemia by reducing
Kikuchi T; Orihara K; Oikawa F; Han SI; Kuba M; Okuda K; Satoh A; Osaki Y; Takeuchi Y; Aita Y; Matsuzaka T; Iwasaki H; Yatoh S; Sekiya M; Yahagi N; Suzuki H; Sone H; Nakagawa Y; Yamada N; Shimano H
Mol Metab; 2016 Nov; 5(11):1092-1102. PubMed ID: 27818935
[TBL] [Abstract][Full Text] [Related]
4. Hyperlipidemia and hepatitis in liver-specific CREB3L3 knockout mice generated using a one-step CRISPR/Cas9 system.
Nakagawa Y; Oikawa F; Mizuno S; Ohno H; Yagishita Y; Satoh A; Osaki Y; Takei K; Kikuchi T; Han SI; Matsuzaka T; Iwasaki H; Kobayashi K; Yatoh S; Yahagi N; Isaka M; Suzuki H; Sone H; Takahashi S; Yamada N; Shimano H
Sci Rep; 2016 Jun; 6():27857. PubMed ID: 27291420
[TBL] [Abstract][Full Text] [Related]
5. Absence of gravin-mediated signaling inhibits development of high-fat diet-induced hyperlipidemia and atherosclerosis.
Fan Q; Yin X; Rababa'h A; Diaz Diaz A; Wijaya CS; Singh S; Suryavanshi SV; Vo HH; Saeed M; Zhang Y; McConnell BK
Am J Physiol Heart Circ Physiol; 2019 Oct; 317(4):H793-H810. PubMed ID: 31441691
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia.
Ng R; Wu H; Xiao H; Chen X; Willenbring H; Steer CJ; Song G
Hepatology; 2014 Aug; 60(2):554-64. PubMed ID: 24677249
[TBL] [Abstract][Full Text] [Related]
7. Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation.
Ma KL; Liu J; Wang CX; Ni J; Zhang Y; Wu Y; Lv LL; Ruan XZ; Liu BC
Cardiovasc Res; 2013 Dec; 100(3):450-60. PubMed ID: 24068000
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional profiling of PPARα-/- and CREB3L3-/- livers reveals disparate regulation of hepatoproliferative and metabolic functions of PPARα.
Ruppert PMM; Park JG; Xu X; Hur KY; Lee AH; Kersten S
BMC Genomics; 2019 Mar; 20(1):199. PubMed ID: 30866796
[TBL] [Abstract][Full Text] [Related]
9. Dipyridamole Inhibits Lipogenic Gene Expression by Retaining SCAP-SREBP in the Endoplasmic Reticulum.
Esquejo RM; Roqueta-Rivera M; Shao W; Phelan PE; Seneviratne U; Am Ende CW; Hershberger PM; Machamer CE; Espenshade PJ; Osborne TF
Cell Chem Biol; 2021 Feb; 28(2):169-179.e7. PubMed ID: 33096051
[TBL] [Abstract][Full Text] [Related]
10. Constitutive androstane receptor activation decreases plasma apolipoprotein B-containing lipoproteins and atherosclerosis in low-density lipoprotein receptor-deficient mice.
Sberna AL; Assem M; Xiao R; Ayers S; Gautier T; Guiu B; Deckert V; Chevriaux A; Grober J; Le Guern N; Pais de Barros JP; Moore DD; Lagrost L; Masson D
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2232-9. PubMed ID: 21778422
[TBL] [Abstract][Full Text] [Related]
11. CREBH Systemically Regulates Lipid Metabolism by Modulating and Integrating Cellular Functions.
Nakagawa Y; Araki M; Han SI; Mizunoe Y; Shimano H
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579081
[TBL] [Abstract][Full Text] [Related]
12. Dose-dependent effects of siRNA-mediated inhibition of SCAP on PCSK9, LDLR, and plasma lipids in mouse and rhesus monkey.
Jensen KK; Tadin-Strapps M; Wang SP; Hubert J; Kan Y; Ma Y; McLaren DG; Previs SF; Herath KB; Mahsut A; Liaw A; Wang S; Stout SJ; Keohan C; Forrest G; Coelho D; Yendluri S; Williams S; Koser M; Bartz S; Akinsanya KO; Pinto S
J Lipid Res; 2016 Dec; 57(12):2150-2162. PubMed ID: 27707816
[TBL] [Abstract][Full Text] [Related]
13. Hepatic CREB3L3 controls whole-body energy homeostasis and improves obesity and diabetes.
Nakagawa Y; Satoh A; Yabe S; Furusawa M; Tokushige N; Tezuka H; Mikami M; Iwata W; Shingyouchi A; Matsuzaka T; Kiwata S; Fujimoto Y; Shimizu H; Danno H; Yamamoto T; Ishii K; Karasawa T; Takeuchi Y; Iwasaki H; Shimada M; Kawakami Y; Urayama O; Sone H; Takekoshi K; Kobayashi K; Yatoh S; Takahashi A; Yahagi N; Suzuki H; Yamada N; Shimano H
Endocrinology; 2014 Dec; 155(12):4706-19. PubMed ID: 25233440
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques.
Tang JJ; Li JG; Qi W; Qiu WW; Li PS; Li BL; Song BL
Cell Metab; 2011 Jan; 13(1):44-56. PubMed ID: 21195348
[TBL] [Abstract][Full Text] [Related]
15. Beneficial Effects of SREBP Decoy Oligodeoxynucleotide in an Animal Model of Hyperlipidemia.
An HJ; Kim JY; Gwon MG; Gu H; Kim HJ; Leem J; Youn SW; Park KK
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31952262
[TBL] [Abstract][Full Text] [Related]
16. Docosahexaenoic acid inhibits proteolytic processing of sterol regulatory element-binding protein-1c (SREBP-1c) via activation of AMP-activated kinase.
Deng X; Dong Q; Bridges D; Raghow R; Park EA; Elam MB
Biochim Biophys Acta; 2015 Dec; 1851(12):1521-9. PubMed ID: 26327595
[TBL] [Abstract][Full Text] [Related]
17. Sterol regulatory element-binding protein family as global regulators of lipid synthetic genes in energy metabolism.
Shimano H
Vitam Horm; 2002; 65():167-94. PubMed ID: 12481547
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion.
VerHague MA; Cheng D; Weinberg RB; Shelness GS
Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2501-8. PubMed ID: 24030551
[TBL] [Abstract][Full Text] [Related]
19. 3-Hydroxyanthralinic acid metabolism controls the hepatic SREBP/lipoprotein axis, inhibits inflammasome activation in macrophages, and decreases atherosclerosis in Ldlr-/- mice.
Berg M; Polyzos KA; Agardh H; Baumgartner R; Forteza MJ; Kareinen I; Gisterå A; Bottcher G; Hurt-Camejo E; Hansson GK; Ketelhuth DFJ
Cardiovasc Res; 2020 Oct; 116(12):1948-1957. PubMed ID: 31589306
[TBL] [Abstract][Full Text] [Related]
20. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.
Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS
Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
